DPP4 and pancreatic neoplasm: Using a panel of human pancreatic cancer cell lines established from patients at different stages of their diseases and tumour tissue arrays from patients with pancreatic cancer, we found that the overexpressed target antigens recognised by these two novel antibodies are integrin α3 and CD26.